Skinvive™ By Juvéderm® is a groundbreaking injectable treatment designed to enhance skin hydration and smoothness, particularly in the cheek area. Unlike traditional dermal fillers that add volume, SKINVIVE™ focuses on improving skin quality by delivering hyaluronic acid microdroplets directly into the dermis, resulting in a radiant and refreshed appearance.
Skinvive™ is the first and only FDA-approved hyaluronic acid (HA) microdroplet injectable in the U.S. specifically formulated to improve cheek skin smoothness. It works by increasing hydration within the skin, leading to a lasting glow that can persist for up to six months with optimal treatment.
SKINVIVE™ is administered through a series of tiny, intradermal microdroplet injections into the dermis layer of the skin. This technique ensures even distribution of hyaluronic acid, enhancing the skin's ability to retain moisture without altering facial volume or shape.
SKINVIVE™ is generally well-tolerated, but as with any injectable treatment, some patients may experience mild side effects, including:
It's important to consult with a qualified healthcare provider to determine if SKINVIVE™ is appropriate for you, especially if you have a history of severe allergies or are allergic to lidocaine or Gram-positive bacteria proteins.
The cost of SKINVIVE™ treatments can vary based on geographic location, provider expertise, and the number of syringes used.